ArticleFuture science OA2019
Glycemic control and survival of patients with coexisting diabetes mellitus and gastric or esophageal cancer.
Article in Future science OA, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 14 citations in OpenAlex.
- Type 2 diabetes mellitus confers unfavorable short- and long-term outcomes in patients undergoing esophagectomy.Surgical endoscopy · 2026Article
- Impact of diabetes mellitus in cancer.The Indian journal of medical research · 2026Review
- Effect of comorbidity classes on survival of patients with gastrointestinal tract cancer.BMC cancer · 2025Observational
- SH3 domain‑binding glutamic acid‑rich protein‑like 3 is associated with hyperglycemia and a poor outcome in Epstein‑Barr virus‑negative gastric carcinoma.Oncology letters · 2025Article
- Diabetes, metformin use, and survival in esophageal cancer: a population-based cohort study.JNCI cancer spectrum · 2023Article
- Cancer, diabetes, survival and glycemic control: a large multisite analysis.Future science OA · 2022Article
- Gastric adenocarcinoma: 1-year overall survival, disability-adjusted life years, years of life lost, and prognostic factors-a single-institution experience.Frontiers in oncology · 2022Article
- The Relationship between Diabetes Mellitus and Gastric Cancer and the Potential Benefits of Metformin: An Extensive Review of the Literature.Biomolecules · 2021Review
- Implications of neuroendocrine tumor and diabetes mellitus on patient outcomes and care: a matched case-control study.Future science OA · 2021Article
- Survival and glycemic control in patients with co-existing squamous cell carcinoma and diabetes mellitus.Future science OA · 2021Article
- Mortality and glycemic control among patients with diabetes mellitus and uterine or ovarian cancer.Future science OA · 2020Article
- Survival and glycemic control in patients with coexisting lymphoma and diabetes: a case-control analysis.Future science OA · 2020Article
- Mortality and glycemic control among patients with acute and chronic myeloid leukemia and diabetes: a case-control study.Future science OA · 2020Article
- Feasibility of ERAS in Patients With Gastric Cancer Complicated by Diabetes Mellitus.Technology in cancer research & treatmentReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo examine effects of diabetes mellitus (DM) on survival in gastric or esophageal (GE) cancer and the cancers' effects on glycemic control. MATERIALS &
methodsPatients with GE cancer with and without DM were matched 1 to 1 (2006-2016). Characteristics were compared and survival assessed with Kaplan-Meier method and Cox regression. Mixed models compared hemoglobin A
resultsAmong DM cases, mean hemoglobin A
conclusionGE cancer and its treatment did not affect glycemic control. Risks of death and progression were greater for patients with DM than patients without DM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.